(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(3-cyanophenyl)propanoic acid, 98%, 10g

(2E)-3-(2-ethoxyphenyl)-1-(2-methylphenyl)prop-2-en-1-one, 95.0%, 10g

Ethyl stearate, 95.0%, 100g

2-(2,5-Dimethyl-1H-pyrrol-1-yl)-5-nitropyridine, 98%, 1g

5-Chloro-1,3-dimethyl-1H-pyrazole-4-carbonitrile, 95%, 100mg

NADPH tetrasodium salt, 500 mg

fmoc-E-acp-oh, 98.0%, 5g

Tellurium(IV) Oxide>98.0%(W)25g

Accessories exchange block for reaction vessels, Gesch. for, 54 reaction vials 0.5 ml, 1 piece

5,11-Dihydropyrido[2,3-b][1,4]benzodiazepin-6-one, 95.0%, 25g

1H-Pyrazol-4-ylmethylamine dihydrochloride, 95.0%, 5g

4-(4-Carboxyphenyl)piperazine-1-carboxylic acid tert-butyl ester, 95.0%, 25g

(R)-8-(Benzyloxy)-5-(2-((5,6-diethyl-2,3-dihydro-1H-inden-2-yl)amino)-1-hydroxyethyl)quinolin-2(1H)-one, 98%, 250mg